CORE--SYNTHETIC CHEMISTRY AND ANALYTICAL SERVICES
核心--合成化学和分析服务
基本信息
- 批准号:6396865
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2001-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The primary role of the chemistry department at the CTRC Research
Foundation is the synthesis and analysis of new chemotherapeutic analogs
for in vitro and in vivo evaluation. The chemistry laboratories have all
of the personnel, equipment and facilities necessary to fulfill the
requirements of this core.
The Chemistry Core will synthesize compounds including oligonucleotides,
nucleosides/nucleotides, and non-nucleoside reverse transcriptase
inhibitors to determine structure-activity relationships for Program 1.
The Chemistry Core will also support oligonucleotides for Program 2 for
footprinting studies; synthesis of specific oligonucleotides for Program
3 for probes for screening of clones; and production of compounds (small
scale-up) for in vivo testing carried out in Program 4.
Our general approach will be, first, to identify the most efficient
synthetic route to the target compound using the synthetic knowledge of
the chemistry staff and by searching the literature for known reactions
which achieve the chemical transformations needed in the synthesis of the
target. Our staff is trained in the use of on-line searching of STN
International electronic databases such as Chemical Abstracts, Beilstein,
and CAS REACT. Next, a time table will be drawn to assure that the
compound can be prepared and characterized by the date required by the
program leader. The synthetic route will be approved by the Core Leader
and assigned to a synthetic chemist. The progress of the synthesis will be
monitored weekly to insure progress is being made. Intermediates and final
product will be fully characterized and purity determined using the
analytical instrumentation located in-house and described in the
analytical section. Strict guidelines will be adhered to in the quality of
product prepared for the NCDDG. Final product will be submitted to the
Program Leader with a written report indicating the synthetic route
followed and the analytical data generated to characterize the compound
and determine its purity.
化学系在CTRC研究中心的主要作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander L Weis其他文献
Alexander L Weis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander L Weis', 18)}}的其他基金
AMPLIFIED FLUORESCENT REPORTERS FOR AVIDIN-BIOTIN TESTS
用于抗生物素蛋白-生物素测试的放大荧光报告基团
- 批准号:
6143514 - 财政年份:2000
- 资助金额:
-- - 项目类别: